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ABBREVIATIONS 
Ca
2+
, calcium; CaM, Calmodulin; NCS-1, Neuronal Calcium Sensor-1; CaBP, Calcium 
Binding Protein; Cav, Voltage Gated Ca
2+
 Channel; CDI, Ca
2+
 Dependent Inactivation; CDF, 
Ca
2+
 Dependent Facilitation; CNS, Central Nervous System; PBS, Phosphate Buffered 
Saline; NTA, Nitrilotriacetic acid; EGTA, Ethylene Glycol Tetraacetic Acid; EDTA, 
Ethylenediaminetetraacetic acid; SDS, Sodium Dodecyl Sulfate; HEPES, 2-[4-(2-
hydroxyethyl)piperazin-1-yl] ethanesulfonic acid; DTT, Dithiothreitol; HRP, Horse Radish 
Peroxidase; ECL, Enhanced ChemiLuminescence; ITC, Isothermal Titration Calorimetry; 
NMR, Nuclear Magnetic Resonance; COSY, Correlation Spectroscopy; HSQC, 
Heteronuclear Single Quantum Correlation;NOESY, Nuclear Overhauser Spectroscopy; 
TOCSY, Total Correlation Spectroscopy; TOCSY, Total Correlation Spectroscopy. 
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ABSTRACT 
In neurons, entry of extracellular calcium (Ca
2+
) into synaptic terminals through 
Cav2.1 (P/Q-type) Ca
2+
 channels is the driving force for exocytosis of neurotransmitter 
containing synaptic vesicles. This class of Ca
2+
-channel is, therefore, pivotal during normal 
neurotransmission in higher organisms. In response to channel opening and Ca
2+
-influx, 
specific Ca
2+
-binding proteins associate with cytoplasmic regulatory domains of the P/Q-
channel to modulate subsequent channel opening. Channel modulation in this way influences 
synaptic plasticity with consequences for higher level processes such as learning and memory 
acquisition. 
The ubiquitous Ca
2+
-sensing protein Calmodulin (CaM) regulates the activity of all types of 
mammalian voltage gated Ca
2+
 channel, including P/Q class, by direct binding to specific 
regulatory motifs. More recently, experimental evidence has highlighted a role for additional 
Ca
2+
-binding proteins, particularly of the CaBP and NCS families in the regulation of P/Q 
channels. NCS-1 is a protein found from yeast to man and which regulates a diverse number 
of cellular functions. Physiological and genetic evidence indicates that NCS-1 regulates P/Q 
channel activity including calcium-dependent facilitation although a direct physical 
association between the proteins has yet to be demonstrated.  
In this study we aimed to determine if there is a direct interaction between NCS-1 and the C-
terminal cytoplasmic tail of Cav2.1 alpha subunit. Using distinct but complimentary 
approaches including in vitro binding of bacterially expressed recombinant proteins, 
fluorescence spectrophotometry, ITC, NMR and expression of fluorescently tagged proteins 
in mammalian cells we show direct binding and demonstrate that it can be competed for by 
CaM. We speculate about how NCS-1/Cav2.1 association might add to the complexity of 
calcium channel regulation mediated by other known calcium sensing proteins and how this 
might help to fine tune neurotransmission in the mammalian central nervous system. 
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Cav2.1 P/Q-Type channels are responsible for Ca
2+
 entry into synaptic terminals in 
many brain regions (1). P/Q-type function is therefore pivotal in the regulation of 
neurotransmitter release and communication throughout the central nervous system (CNS). 
Indeed, mutations in the gene encoding the human P/Q-1 subunit are responsible for a 
number of clinically relevant neurological disorders (2). An interesting feature of many Cav 
proteins (Cav1.x and Cav2.x), including the P/Q channel, is that channel activity is itself 
regulated by Ca
2+
 (3). Ca
2+
 dependent channel modulation manifests as two distinct 
phenomena referred to as Ca
2+
 dependent inactivation (CDI, (4)) and Ca
2+
 dependent 
facilitation (CDF, (5)). CDI represents a mechanism by which channels become refractory to 
further opening in the presence of a sustained stimuli whereas CDF manifests as the opposite 
process whereby Ca
2+
 augments channel currents (6). Specific Ca
2+
-binding proteins can 
respond to Ca
2+
 entry through Cav channels by interacting directly with regulatory motifs 
present in the intracellular domains of the -subunit (7-10). These interactions, by currently 
poorly understood mechanisms, alter channel behaviour to elicit either CDI or CDF. CDI and 
CDF both have direct impact on synaptic neurotransmitter release, strength of synaptic 
signalling and ultimately synaptic plasticity. Understanding the basic modes of Cav regulation 
at the molecular level therefore generates insights into more abstract, higher level, processes 
including learning, memory acquisition, and reasoning. 
Of the characterised Ca
2+
-binding proteins that control Cav activity, the ubiquitous small EF-
hand containing protein calmodulin (CaM) has been most intensively studied. CaM has been 
shown to interact with a consensus isoleucine-glutamine ‘IQ’ motif present in the carboxy 
terminus of the channel although the precise details of the interaction differs for Cav1.x and 
Cav2.x subtypes (11, 12). A second Ca
2+
-dependent CaM binding motif immediately C-
terminal to the IQ domain has also been characterised in Cav2.1 P/Q-type channels (13). This 
CaM Binding Domain (CBD) has been found to influence P/Q channel activity in some 
studies (13) but not others (7) and its true significance remains somewhat controversial.   
A number of CaM-related Ca
2+
-binding proteins are enriched in the mammalian CNS and 
have been found to modulate the properties of Cav channels. In all instances thus far 
characterised, channel regulation is distinct from that observed with CaM suggesting none-
redundant functions which have been speculated to permit complex modes of channel 
regulation and neuronal signalling (12). Presently two CaM related Ca
2+
-binding proteins, 
Ca
2+
 Binding Protein 1 (CaBP1) and Visinin Like Protein-2 (VILIP-2) have been shown to 
directly interact with P/Q-Type -subunits to exert unique regulatory outcomes (10, 14). 
Large numbers of additional CaM-related small EF-hand containing proteins are also 
expressed in the mammalian CNS. Neuronal Ca
2+
 Sensor-1 (NCS-1) is a CaM-related protein 
that is evolutionarily conserved from yeast to man (15) and that has been implicated in 
specific human neuronal disorders (16-19). Evidence for a regulatory role of NCS-1 on P/Q-
Type channels has been reported based on physiological experiments in mammalian cells, 
including an effect on CDF, (20-22) and a genetic study in Drosophila (23) although no 
direct interaction between the two proteins has thus far been demonstrated.  
In this paper we aimed to use exclusive yet complimentary analytical methods to rigorously 
determine if there is a direct interaction between NCS-1 and the -subunit of the P/Q type 
channel and to provide the first evidence an interaction between a defined region of the C-
terminal domain of the P/Q -subunit and NCS-1. We show that a segment of P/Q encoding 
the IQ motif and CBD interacts with NCS-1 in a Ca
2+
 dependent manner. Using mutagenesis 
and NMR experiments we further refine the NCS-1 binding site to the IQ motif and show that 
the interaction is competitive with CaM. We provide further evidence using an ex vivo HeLa 
cell model that NCS-1 and the C-terminal tail of Cav2.1 interact. These novel observations 
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expand the repertoire of P/Q-Type interacting proteins and add to the potential variety of 
modes by which such channels can be controlled. 
EXPERIMENTAL PROCEDURES 
Cloning - DNA constructs and molecular biology – GST-NCS-1 (24) and NCS-1-mCherry 
(18) plasmids were as previously described. The coding sequence for human CaM was PCR 
amplified from oligo dT(15) primed HeLa cell RNA and reverse transcribed first strand cDNA 
template with the following primer pair (based on Genbank Accession: M19311) containing 
restriction endonuclease sites (underlined) for sub-cloning into the N-terminal GST tag vector 
pGex6P-1 (Amersham Biosciences, UK): Sense (BamHI) 5’-
ATATGGATCCATGGCTGACCAACTGACTG-3’; Antisense (XhoI) 5’-
ATATCTCGAGTCACTTTGCTGTCATCATTTG-3’. GST-P/Q, encoding residues 1898-
2035 of rat P/Q channel-1 subunit (Genbank Accession: NM_012918) was PCR amplified 
from rat brain single strand cDNA template with the following primer pair containing 
restriction endonuclease sites (underlined) for sub-cloning into pGex6P-1: Sense (BamHI) 5’-
ATATGGATCCAAGTCCACGGACCTGACAGTG-3’; Antisense (XhoI) 5’-
ATATCTCGAGCTAGGGGAGGTAGTGTTCGCTGTC-3’. GST-CBD (residues 1950-
2035) of rat P/Q channel-1 subunit  was PCR amplified from the GST-P/Q template using 
the P/Q reverse primer and the following sense primer containing a BamHI site (underlined) 
for subsequent sub-cloning into pGex6P-1: 5’-
ATATGGATCCGAGGGAGGACCCAGCCAAAAC-3’. GST-P/QIM→EE was generated by 
site directed mutagenesis of GST-P/Q plasmid using Quikchange
®
 reagents and protocol 
(Agilent Technologies, UK) and the following primer pair: Sense 5’-
AAGATCTACGCAGCCATGATGGAGGAGGAGTACTACCGGCAGAGCAAG-3’; 
Antisense5’-
CTTGCTCTGCCGGTAGTACTCCTCCTCCAGCAGGGCTGCGTAGATCTT-3’ 
SUMO-tagged residues 1909-2035 of the rat P/Q channel-1 subunit was PCR amplified 
from the GST-P/Q template encoding residues 1898-2035 with the following primer pair for 
sub-cloning into the pOPINS vector: Sense 5`-
GCGAACAGATCGGTGGTGCAGCCATGATGATCATGGAG-3`; Antisense 5`-
ATGGTCTAGAAAGCTTTAGGGGAGGTAGTGTTCGCTGT-3`. Ligation of the PCR 
product and KpnI/HindIII digested vector employed the infusion reaction method (Clontech) 
according to the manufacturer’s protocol.  
Myristoylated PQ (1898-2035, 
myr
PQ-YFP) was constructed as follows: A DNA fragment 
encoding the myristoylation sequence taken from (25), was inserted between the XhoI and 
HindIII sites of pEYFP-N1 (Clontech) to generate p
myr
EYFP-N1. PQ
1898-2035
 was PCR 
amplified from the existing pGex template with the following primer pair containing 
restriction endonuclease sites (underlined) for subsequent sub-cloning into p
myr
EYFP-N1: 
Sense (HindIII) 5’-ATAT AAG CTT AAG TCC ACG GAC CTG ACA GTG-3’; Antisense 
(SacII) 5’-ATAT CCG CGG GGG GAG GTA GTG TTC GCT GTC-3’. All constructs were 
verified by dideoxy sequencing (The Sequencing Service, University of Dundee, UK). 
Cell culture and plasmid transfections - HeLa cells were cultured in DMEM supplemented 
with 10% (v/v) foetal bovine serum, 1% (v/v) Penicillin/Streptomyocin and 1% (v/v) non-
essential amino acids. All cells were maintained in a humidified atmosphere of 95% air/ 5% 
CO2 at 37 °C. Cells were plated onto sterile 13mm round coverslips at a density of 0.25x10
6 
cells/well. After 24 hours, cells were transiently transfected with the indicated expression 
vectors using GeneJuice transfection reagent (Novagen) according to the manufacturer’s 
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protocol. For single and double transfections 1μg of each plasmid was used. 
Cell fixation and confocal imaging analysis - 24 hours post-transfection cells on coverslips 
were washed with Phosphate Buffered Saline (137mM NaCl, 2.7mM KCl, 10mM Na2PO4, 
2mM NaH2PO4, pH7.4), and then fixed with 4%(v/v) Formaldehyde in PBS for 6 minutes at 
room temperature. Coverslips were subsequently air-dried and mounted onto microscope 
slides using Prolong anti-fade glycerol (Life Technologies). Fixed cells were imaged using a 
Leica TCS-SP2 confocal system (Leica Microsystems, Heidelberg, Germany) with pinhole 
set to 1 Airy unit and a 63x oil immersion objective with a numerical aperture of 1.3. Images 
were exported as TIFF files and compiled, processed and analysed with ImageJ and 
CorelDraw X6 applications. 
In vitro Binding Assays - In vitro protein binding assays – 5M of GST-fusion protein (GST-
P/Q, GST-P/Q
IM→EE
 or GST-CBD) was immobilised on to 30l glutathione-agarose resin 
(Thermo Scientific) that had been pre-washed in binding buffer (BB, 150mM KCl, 20mM 
HEPES (pH7.4), 10%(v/v) Glycerol, 5mM NTA, 5mM EGTA, 1mM DTT, 0.1%(v/v) NP-40) 
or BB supplemented with 1M free Ca2+ (BB+Ca2+) by incubation for 30min with constant 
agitation at 4
o
C. GST-free NCS-1 and CaM were added to samples at 5M (total final 
binding assay volumes were 100l) and incubations continued for 1hr with constant agitation 
at 4
o
C. For competition binding assays 5M GST-P/Q was pre-bound to glutathione-agarose 
resin in BB+Ca
2+
 by incubation for 30min at 4
o
C with constant agitation. 5M NCS-1 was 
then added to samples in the presence of increasing concentrations of CaM ranging from 
0M to 10M. Binding reactions were continued for 1hr at 4oC with constant agitation. For 
the Ca
2+
 dose dependency of the NCS-1/GST-P/Q interaction, 1M GST-P/Q was incubated 
with 1M NCS-1in the presence of increasing concentrations of free Ca2+. For all binding 
assays glutathione-agarose pellets were collected by centrifugation (3,000rpm, 1min, 4
o
C), 
washed three times with 1ml of BB or BB+Ca
2+
 and bound proteins extracted by boiling of 
final bead pellets for 5min in 50l of SDS dissociation buffer (125mM HEPES (pH 6.8), 10% 
(w/v) sucrose, 10% (v/v) glycerol, 4% (w/v) SDS, 1% (v/v) β-mercaptoethanol, 
2mM EDTA). Proteins were resolved on 4-12% Tris-Glycine gradient gels (Novex
®
, Life 
Technologies, UK) and transferred to nitrocellulose membranes for Western blotting by 
transverse electrophoresis. 
Western Blots - Nitrocellulose filters were blocked by incubation in blocking solution (3% 
(w/v) skimmed milk powder in PBS) for 1hr at room temperature. Filters were subsequently 
incubated with primary antibody: rabbit anti-NCS-1 (1:1000 (26)) or rabbit anti-Calmodulin 
(1:500, AbCam, UK) diluted in blocking solution, overnight at 4
o
C with constant agitation. 
Filters were washed x3 in PBS supplemented with 0.05% (v/v) Tween-20 (PBST) and twice 
with PBS before incubation with HRP-conjugated species specific secondary antibody 
(1:400, anti-Rabbit HRP, Sigma, UK) in blocking solution for 1hr at room temperature. 
Filters were washed x3 with PBST and twice with PBS prior to application of ECL reagents 
and visualisation of immunoreactivity using a Chemidoc automated gel/blot documentation 
system (Biorad, UK). Densitometry analysis of developed Western blots was performed 
using Quantity-1 software (Biorad, UK). For the Ca
2+
 dose dependency of the NCS-1/GST-
P/Q interaction, densitometry data was analysed by applying non-linear curve fitting with 
OriginPro8 software (OriginLab, MA, USA). 
Synthetic Peptide - The peptide used corresponds to residues 1903-1929 of the human P/Q 
receptor. The synthetic P/Q peptide: TVGKIYAAMMIMEYYRQSKAKKLQAMR 
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(hereafter referred to as PQIQ peptide) was purchased from GenicBio, China. The peptide 
was delivered >95% pure. 
Protein Expression and Purification - NCS-1 was expressed in E.coli strain BL21 (DE3) 
(Novagen) and purified as previously described (27). Expression was induced overnight at 
18ºC; cells were harvested, resuspended into lysis buffer (50mM Tris.HCl, pH7.5, 200mM 
NaCl, 5mM CaCl2, Complete EDTA Free Protease inhibitor (Roche Applied Science)), lysed, 
centrifuged, filtered and loaded to the Hiprep 16/10 Phenyl FF High Sub (GE Healthcare) 
column which was pre-equilibrated with Buffer-A (50mM Tris.HCl, pH7.5, 200mM NaCl & 
5mM CaCl2). The column was extensively washed with Buffer A, and NCS-1 eluted using 
MilliQ water. The eluted protein was buffer exchanged into 50mM Tris, pH7.4, 500mM 
NaCl, the N-terminus his- tag removed by incubating the protein overnight at 4
o
C  using TEV 
protease (1:20 molar ratio of TEV protease:NCS-1). His-tagged uncleaved NCS-1 and TEV 
protease were separated for cleaved NCS-1 using a HisTrap FF 5mL affinity column (GE 
Healthcare). The cleaved NCS-1 was further purified using Superdex 75 Hiload 26/60 
(Amersham Biosciences) size exclusion column (50mM TrisHCl, pH7.5, 150mM NaCl). The 
purity of the sample was assessed by SDS-Page gel and deemed to be >95% pure. Eluted 
peak was concentrated and stored at -80
o
C. 
Calmodulin was cloned into a pET-15b (Novagen) vector (gift from Dr. Ashraf Kitmitto, 
University of Manchester) and expressed in E.coli strain BL21 (DE3) (Novagen) at 37
o
C. 
Harvested cells were resuspended in lysis buffer (50mM Tris (pH 7.5), 2mM DTT), disrupted 
using the French press (Sim Aminco) at 1000 PSI, centrifuged and the supernatant was 
recovered, CaCl2 added to a final concentration of 2mM and protein solution loaded onto a 
20mL HiPrep
TM
 phenyl sepharose hydrophobic column (GE Healthcare), pre-equilibrated 
with CaM buffer A (50mM Tris, pH 7.5, 200mM NaCl, 2mM CaCl2, 0.5mM DTT). The 
column was washed with CaM buffer A, followed by buffer B (50mM Tris, pH 7.5, 0.5mM 
CaCl2, 0.5mM DTT) and pure calmodulin eluted with CaM buffer C (50mM Tris, pH 7.5, 
1mM EGTA, 0.5mM DTT). The protein was further purified using a 26/60 Superdex
TM
 75 
(GE Healthcare) size exclusion column pre-equilibrated with CaM gel filtration (GF) buffer 
(50mM Tris, pH7.5, 200mM NaCl, 10mM CaCl2, 0.5mM DTT). The sample was loaded 
before isocratic elution. The purity of the sample was assessed by SDS-PAGE gel and 
deemed to be >95% pure. CaM was dialysed against water and lyophilised before storage at -
20°C.  
15
-N-labelled SUMO-tagged PQIQ 1909-2035 was expressed in E. coli BL21(DE3) in 2M9 
medium with overnight incubation 18
o
C and cells are harvested and resuspended into the 
lysis buffer (50mM Tris.HCl (pH7.4), 500mM NaCl) supplemented with Compete EDTA 
Free Protease inhibitor (Roche Applied Science). The cells were lysed, 250µg of bovine 
pancreas Deoxyribonuclease I (Sigma) added, sample centrifuged and supernatant collected, 
filtered through 0.22µ acrodisc and loaded onto a HisTrap 5ml FF column (GE Healthcare)  
pre-equilibrated with buffer A (50 mM Tris.HCl (pH7.4), 500  mM NaCl). Unbound proteins 
were removed through extensive wash with buffer A, with further successive washes with 
buffer A containing 10mM, 25mM and 50mM Imidazole. Sumo-tagged PQIQ 1909-2035 
was eluted with buffer A containing 250mM imidazole, buffer-exchanged into SUMO 
cleavage buffer (50mM Tris (pH7.4), 150mM NaCl), SUMO protease was added and 
solution incubated overnight.  Cleaved PQIQ 1909-2035 was separated from the His-SUMO 
tag by reloading the sample onto the HisTrap 5ml FF column.  PQIQ 1909-2035 was further 
purified using a Superdex 57 26/60 (GE Healthcare) size-exclusion column.  The eluted 
protein was dialysed against Milli Q water and stored as lyophilised samples. Confirmation of 
the identity of the purified PQIQ 1909-2035 was obtained through MALDI-TOF mass 
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spectrometry performed on unlabelled PQIQ 1909-2035 prepared using the identical 
procedure as described above. 
Isothermal Titration Calorimetry - ITC experiments were performed using a MicroCal ITC200 
instrument. Due to limitations in the PQIQ peptide solubility, NCS-1 was titrated into the 
peptide.  Ca
2+
/NCS-1 at 1mM was prepared by buffer exchange using a PD10 column 
equilibrated in 50mM Tris (pH7.5), 50mM NaCl, 5mM CaCl2  and the PQIQ peptide solution 
at 100M was prepared using the same buffer. If necessary, minor adjustments were made to 
the pH of the peptide solution.  Experiments were carried out using 200µl of 100M PQIQ 
peptide in the cell and 60µl of 1mM NCS-1 in the syringe at 25
o
C. One injection of 0.2l,  
followed by 20 injections of 2l were made with 180sec spacing to allow the baseline to 
return after each injection. All experiments were performed in triplicate. The data was 
analysed with a one site (three parameters) curve fitting carried out using the MicroCal-
supported ITC module within Origin version 7. 
Spectrofluorimetry - To monitor intrinsic tryptophan fluorescence of NCS proteins (28, 29), 
purified recombinant NCS-1 at a concentration of 1μM in a buffer (50mM Tris (pH 7.5), 
50mM NaCl, 5mM CaCl2) was excited at room temperature with 280nm wavelength light 
and emission measured between 290-410nm with a slit width of 20nm using a CARY Eclipse 
spectrofluorimeter . The PQIQ  peptide (stocks ranging from 50M-1mM) was then added to 
give an incremental increase in peptide concentration and emission spectra acquired after 
each addition. Experiments were performed in triplicate. The data for the measured 
tryptophan fluorescence change at each peptide concentration were fitted to a logistic 
equation using non-linear curve fitting in OriginPro 
TM
 9.0.  
NMR Spectroscopy - NCS-1 was prepared in Tris buffer (pH 6.8) in the presence of 5mM 
CaCl2. NMR spectra were recorded at 298K on Bruker Avance II 800 and 600 MHz 
spectrometers equipped with CryoProbes. Data were processed using the Bruker Software 
TopSpin and analysed using CCPN software (30). Sequence specific assignment of the PQIQ 
peptide was obtained using homonuclear 2D-TOCSY, COSY and NOESY data. 
13
C,
15
N-
filtered TOCSY and NOESY experiments were used to assigned the peptide resonances in 
complex with 
13
C/
15
N NCS-1.  
RESULTS 
The aim of this study was to test, using a range of complementary methods, the 
possibility that the small calcium sensing protein NCS-1 directly interacts with the Cav2.1 
P/Q type Ca
2+
 channel as has been indirectly suggested in prior functional studies (20-23). 
With the knowledge that other known small EF-hand Ca
2+
-binding proteins interact with the 
-subunit of the P/Q channel predominantly through motifs located in the C-terminal tail we 
reasoned that the same domains represent the most likely sites for an NCS-1 interaction. In 
initial experiments we generated a recombinant, GST-tagged, form of the P/Q 1 subunit C-
terminal tail domain corresponding to residues 1898-2035 (Figure 1, GST-PQ). This 
fragment encompasses both the IQ motif (IM in the P/Q Type channel) and the CaM binding 
domain (CBD) (10). Two further constructs derived from this precursor were the CBD alone 
(residues 1950-2035, Figure 1, GST-CBD) and an IQ motif mutant whereby the P/Q-channel 
IM residues at positions 1913 and 1914 were mutated to glutamic acid to generate an 
IM→EE double mutant (Figure 1, GSTIM→EE). This mutation has been previously shown to 
abolish CaM dependent CDF and CDI of the human P/Q-Type channel (7). We used these 
constructs to investigate whether recombinant NCS-1 could associate with P/Q-type C-
terminal regulatory domains in vitro. NCS-1 exhibited Ca
2+
-dependent binding to GST-PQ 
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but was not observed to bind to either GST-CBD or GST
IM→EE
 under any tested conditions 
(Figure 1A) suggesting a specific interaction with residues in the IQ region of the channel.  
A Ca
2+
 titration of NCS-1 binding to GST-PQ confirmed the Ca
2+
-dependency of the 
interaction and allowed us to derive a Kd of 0.7M based on densitometry quantification of 
Western blot data (Figure 1B). For comparison we performed the same binding analysis with 
CaM (Figure 1C). Similar to our results with NCS-1, CaM displayed Ca
2+
-dependent binding 
to GST-PQ but no detectable binding under any conditions to either GST-CBD or GST
IM→EE
.  
Our initial data suggested that both NCS-1 and CaM could interact with the same IQ-motif 
region of rat P/Q-Type channel and therefore we extended our binding studies to evaluate the 
potential existence of a common, overlapping, binding site for both proteins. Competitive 
association of both proteins with GST-PQ was assessed by binding of NCS-1 to GST-PQ in 
the presence of increasing concentrations of recombinant CaM (Figure 2). Western blot 
results from these experiments highlighted a clear displacement of NCS-1 from GST-PQ that 
was first apparent at a CaM concentration of between 0.3M and 1M (Figure 2A). 
Densitometry analysis of the Western blot data confirmed a competitive association between 
NCS-1 and CaM for GST-PQ (Figure 2B). Our initial experiments indicated that the IQ like 
motif of the P/Q-type channel is important for interaction with both NCS-1 and CaM and 
therefore in subsequent NMR and ITC analyses we focused on this region of the channel 
only. 
Further testing of the ability of NCS-1 to bind the P/Q type channel and to delineate the NCS-
1 and CaM binding regions of the P/Q-type channel was performed using NMR experiments. 
A sample of 
15
N-labelled P/Q spanning residues 1909 to 2035 (encompassing much of the IQ 
motif and the CBD) was prepared. Addition of CaM shows chemical shift perturbations of 
glycine and tryptophan residues whereas NCS-1 has no effect on either group of residues 
(Figure 3). Glycine and tryptophan residues are located in the CBD region but not in or 
around the IQ segment. Hence, it is clear that NCS-1 does not bind to the CBD of the P/Q 
channel, although there is indication that there is weak CaM binding to this site. 
Knowing from the experiments above that the major site of binding of NCS-1 on the P/Q C-
terminal domain was likely to be the IQ motif, further experiments used a synthetic PQIQ 
peptide.  The intrinsic tryptophan fluorescence of NCS-1 was used to measure interactions 
with the PQIQ peptide, using a smilar approach to that described for the interactions with the 
D2 dopamine receptor peptide(27). NCS-1 has two tryptophan residues; addition of the PQIQ 
peptide resulted in a decrease in fluorescence and allowed titration of the peptide over a range 
of concentrations (Figure 2A). The data for the change in fluorescence versus concentration 
was analysed using a logistic fit. The   dose-response upon titration with the PQIQ indicated 
half-maximal binding at 1.036± 0.07M with a Hill coefficient of 1.7. Hill coefficients 
greater than 1 would be consistent with a 2:1 stoichiometry of peptide binding to NCS-1 
since NCS-1 itself was monomeric(27). Isothermal titration calorimetry (ITC) shows that the 
interaction is entropically-driven. Due to tendency of the protein complex to aggregate at the 
high peptide (100M) and protein concentrations (1mM) required to observed binding by this 
method, it was not possible to obtain reliable equilibrium binding constants using ITC. The 
affinity obtained for NCS-1 interaction with the PQIQ peptide is almost an order of 
magnitude lower than the reported affinities involving the calmodulin lobes; From ITC 
experiments, Kd values of 51±20nM and 4.32±0.39nM were obtained, for, respectively, the 
Ca
2+
/N and Ca
2+
/C lobe binding to the IQ domain of the PQ channel (31). The two lobes in 
NCS-1 are intimately linked and attempts to express the two NCS-1 lobes as independently 
folded domains soluble at micomolar concentrations have been met with little success so far.  
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Therefore, experiments to disentangle the relatively affinities of the two NCS-1 domains for 
the PQIQ peptide have not been possible. 
To determine which region of the PQIQ peptide forms the NCS-1 binding site we again used 
NMR. In these experiments 
13
C/
15
N- NCS-1 was titrated into a sample of the unlabelled 
PQIQ peptide and
13
C/
15
N filtered TOCSY and NOESY data acquired. Analysis of the side-
chain resonances, in particular the methyl and tyrosine resonances, reveal selective line-
broadening for fourteen residues, YAAMMIMEYYRQSK (Figure 5A). Hence, a subset of 
the 27 amino acids in the polypeptide sequence forms the main interaction site for NCS-1 
binding, with the residues beyond this core peptide region further enhancing the interaction. 
The length of this motif correlates well with the recently reported structure of NCS-1 in 
complex with the C-terminus peptide from the human D2 dopamine receptor (PDB Accession 
2YOU). The 14 amino acid motif is short enough for it to bind NCS-1 with a stoichiometry of 
2:1 (peptide:NCS-1) and supports the fluorescence binding data. 
NMR 
1
H-
15
N HSQC of NCS-1 in the presence of two-fold excess of PQIQ show resonances 
which are universally broadened although still discernable to confirm that the protein remains 
folded (Figure 5B). Addition of equimolar amounts of unlabelled CaM/Ca
2+
 to the preformed 
15
N-labelled NCS-1/PQIQ complex led to a complete reversion of the 
1
H-
15
N HSQC C 
spectrum to that of free NCS-1. This is further confirmation that NCS-1 and CaM bind to the 
similar sites on the PQ channel, with, as expected, CaM binding the peptide strong enough to 
displace it from NCS-1.  
The experiments described above show that a direct interaction of NCS-1 with the P/Q C-
terminus could be detected using three distinct in vitro biochemical approaches. In order to 
provide evidence for the interaction of NCS-1 with the P/Q channel regulatory domain in a 
more physiological setting the localisation of these proteins was studied ex vivo in cultured 
HeLa cells. For these experiments we returned to the use of a longer recombinant construct 
encompassing both the IQ and CBD domains of the P/Q C-terminus. We firstly examined the 
cellular localisation of both NCS-1-mCherry (18) and a C-terminally YFP tagged variant of 
P/Q 1898-2035 to which an N-terminal myristoylation consensus sequence had been attached 
(
myr
PQ-YFP). In previous studies this approach has been used to successfully direct isolated 
soluble domains of plasma membrane proteins to the plasma membrane for functional 
analyses (25). NCS-1-mCherry exhibited a predominantly peri-nuclear localisation consistent 
with its association with the TGN in addition to some plasma membrane localisation (Figure 
6A) (32). 
myr
PQ-YFP was observed to target to the plasma membrane and/or to large 
cytosolic puncta (Figure 6A). Plasma membrane association of 
myr
PQ-YFP suggested that 
myristoylation of the peptide was accurately targeting a fraction of PQ to the expected 
location. Interestingly, in cells exhibiting 
myr
PQ-YFP puncta, co-expressed NCS-1-mCherry 
failed to localise to the TGN or plasma membrane and instead co-localised with 
myr
PQ-YFP 
on the enlarged punctate structures (Figure 6B). We quantified these phenomena and were 
able to demonstrate that in 39.5% ± 9.2% of cells co-transfected with NCS-1-mCherry and 
myr
PQ-YFP, puncta were observed and that in 100% of this sub-population NCS-1 protein 
was associated with large 
myr
PQ-YFP positive punctate structures (Figure 6C, NCS-1-mCh + 
myr
PQ-YFP). This was similar to the number of cells exhibiting puncta in 
myr
PQ-
YFP/mCherry controls (43.6% ± 3%, Figure 6C, 
myr
PQ-YFP + mCherry). In contrast, control 
cells expressing NCS-1-mCherry along with EYFP protein exhibited no observable puncta 
formation (Figure 6C, NCS-1-mCh + EYFP). It should be noted that co-localisation of NCS-
1-mCherry with 
myr
PQ-YFP in punctate structures was specific for NCS-1 as no co-
localisation was observed with the soluble mCherry protein in control co-transfections (data 
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not shown). These observations are consistent with a direct interaction of NCS-1-mCherry 
with 
myr
PQ-YFP in a cellular context.  
DISCUSSION 
In this paper we set out to examine whether NCS-1 is able to interact directly with the 
C-terminus of the 1 subunit of P/Q-type channel. To avoid a potentially misleading 
indication of a positive interaction we tested this using three separate in vitro 
biochemical/biophysical assays using either a long construct from the P/Q C-terminus or a 
synthetic IQ domain peptide as well as a test through cellular co-localisation. The use of 
multiple techniques gives a more rigorous approach to addressing the question of whether a 
significant direct interaction does exist. In all cases we were able to detect a direct interaction 
between NCS-1 and P/Q-type Ca
2+
-channels.  
P/Q-type channel regulation by small Ca
2+
-binding proteins is essential in the 
mammalian CNS for the processes of CDI and CDF which drive short-term pre-synaptic 
plasticity (6). Alterations in synaptic plasticity of this form in turn influence information 
processing and neural network behaviour which underpin normal functioning of the CNS 
(33). A large body of experimental evidence has been accrued that describes at the molecular 
level how CaM is able to regulate all Cav-type channels including those of the P/Q-subtype. 
CaM is constitutively associated with P/Q and is considered an auxiliary subunit of the 
channel. Apo-CaM is believed to bind to P/Q at a site outside of, but in close proximity to, 
the Ca
2+
-dependent IQ binding site, as determined using a Förster Resonance Energy 
Transfer approach in cultured mammalian cells (34). It has been speculated that this 
arrangement locates CaM within striking distance of the regulatory IQ motif to ensure fast 
responses to Ca
2+
 influx on channel opening (34). Ca
2+
-dependent binding of CaM to the IQ 
motif is then able to modulate both CDI and CDF depending on the precise nature of the Ca
2+
 
signal. Mechanistically this system has been resolved in elegant experiments showing that 
Ca
2+
 entry through individual P/Q channels selectively activates the CaM C-lobe to mediate 
CDF. Larger Ca
2+
 signals emanating from multiple local channel opening events conversely 
activates the CaM N-lobe to drive CDI (3, 7, 35). Our data confirming a Ca
2+
-dependent 
interaction of CaM with the P/Q-IQ containing motif is consistent with previous biochemical 
(7) and structural analyses (31). A second CaM binding site, the CaM-Binding Domain or 
CBD, has been reported in related studies of P/Q-channel interactions (5, 13). In this study, 
although we have been unable to replicate binding of CaM to this region of the rat 1A CBD 
using pull-down experiments, the NMR data suggests that CaM, but not NCS-1, binds to the 
proposed CBD, albeit rather weakly. The weak nature of this interaction might explain why 
there are discrepancies in the literature regarding the significance of the CBD. Pull-down type 
experiments select for high-affinity interactions whereas NMR approaches are able to detect 
lower affinity transient binding events consistent with these results. Our data help reconcile 
apparently conflicting experimental data whereby some studies do observe a CaM-CBD 
interaction (5, 13) whereas others do not (7).  
NCS-1, a multifunctional Ca
2+
-sensor conserved from yeast to man, has documented roles in 
the regulation of membrane trafficking (36, 37), ion channel activity (38, 39), dopamine 
receptor signalling (27, 40), Long Term Depression (41), autism (18, 42) and memory 
acquisition (43, 44).  NCS-1 exhibits enriched expression in mammalian brain tissue (45) and 
many of the aforementioned functions are related to neuronal activity. NCS-1 interacts with a 
number of targets in common with CaM (24) and a previous functional study identified links 
between NCS-1 and CDF of P/Q-Type channel activity in rat primary neurons (20). Other 
studies have additionally indicated a cellular connection between NCS-1 and P/Q-Type 
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channel activity in bovine adrenal chromaffin cells (21, 22) and Drosophila (23). With this 
information in mind we have tested the possibility that NCS-1 can directly bind to P/Q 
regulatory elements in common with CaM and other EF-hand containing Ca
2+
-sensors (10, 
14). Our data show that NCS-1 can associate with the IQ motif of rat P/Q1A in a Ca
2+
-
dependent manner and that this binding site must overlap to some extent with that of CaM 
since CaM can compete for binding to the same region leading to NCS-1 displacement. This 
is the first example of a CaM-related Ca
2+
-sensing protein behaving in an almost identical 
manner to CaM with respect to IQ binding. Both CaBP1 (10) and VILIP-2 (14) interact with 
the CBD or require this domain for functional activity. CaM binds predominantly to the IQ 
domain with a possible weak interaction with the CBD, and NCS-1 binds only to the IQ 
domain in the presence of Ca
2+
. The weak CaM-CBD interaction that we have observed in 
this study might also help to explain why CaBP1 and VILIP-2 are able to effectively compete 
with CaM at this site (10, 14). 
The precise details of the NCS-1 interaction are still to be elucidated. In rat primary neurons 
NCS-1 appears to play a role during CDF (20) and in Drosophila, loss of the NCS-1 
orthologue Frequenin leads to reduced Ca
2+
 entry into neurons and defective synaptic 
transmission (23). These data suggest that at least one function of NCS-1 is in positively 
regulating P/Q channel opening. Our data now provide an attractive biochemical explanation 
for these cellular studies and act as a platform for further cellular and structural investigations 
studying the interplay between CaM and NCS-1 during regulation of P/Q channel activity. 
CaM is expressed in all neurons and one possibility is that specific neuronal populations that 
also express NCS-1 are able to utilise this Ca
2+
-sensor as an additional modulator of P/Q 
activity. NCS-1 has a higher Ca
2+
 affinity than CaM (15, 46) and therefore could potentially 
interact with the IQ motif over a different range of local Ca
2+
-concentrations to modulate 
activity independently of CaM. As Ca
2+
 concentrations increase CaM could then displace 
NCS-1 to exert its documented roles in CDF and CDI. The N- and C-lobes of CaM, as 
described, exert distinct modes of P/Q-channel regulation. NCS-1, unlike CaM, does not have 
distinct lobes but rather a compact globular structure (47). The orientations of the N and C 
lobes with respect to one another differ in the two proteins, giving rise to different 
conformations of the ligand-binding site. Residues from both lobes in NCS-1 together form a 
large, contiguous solvent exposed hydrophobic ligand-binding crevice, resembling the palm 
of a partially-open hand. In Ca
2+
/CaM-PQIQ complex, the hydrophobic binding pocket is 
more enclosed, resembling a closed hand which envelopes the PQIQ peptide. It is, therefore, 
not possible to model a structure of NCS-1 in complex with the PQIQ peptide based on the 
Ca
2+
/CaM complex structure. It is likely that binding the PQIQ peptide would require a 
significant conformational change to the overall structure of NCS-1 in order to accommodate 
the peptide. 
Using a combination of in vitro biochemical, NMR/ITC biophysical and cellular approaches 
we provide the first evidence for a direct interaction of NCS-1 with P/Q-Type voltage gated 
Ca
2+
 channels. Voltage gated Ca
2+
 channel modulation has direct implications for synaptic 
plasticity and complex neural processing in higher organisms. Our work expands the number 
of small Ca
2+
-sensing proteins able to interact with the essential P/Q-type neuronal channel 
and provides further insights into the complexity in regulation of voltage gated Ca
2+
 channels 
in the mammalian CNS.  Extensive further work will be required to determine the full 
structural basis for the interaction of NCS-1 with the P/Q IQ domain. 
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FIGURE LEGENDS 
FIGURE 1 – NCS-1 and CaM interactions with rat PQ1-subunit C-terminal binding motifs. 
A) Recombinant NCS-1 was incubated with GST-PQ (residues 1898-2035 of rat PQ1 
subunit, encompassing both the IQ and CBD motifs), GST
IM→EE
 (equivalent to the IQ motif 
present in Cav1.x channels) and GST-CBD (residues 1950-2035 of rat PQ1 subunit) in the 
presence or absence of 1M free Ca2+. Bound NCS-1 was detected by Western blotting with 
a specific antibody. This blot is a representative result and averaged data from 3 independent 
binding assays is presented in Supplementary Table 1. B) Densitometry quantification of an 
NCS-1/GST-PQ binding Ca
2+
 dose response. Recombinant NCS-1 (1M) was incubated with 
1M GST-PQ in the presence of increasing concentrations of free Ca2+ and bound protein 
detected by Western blotting with anti-NCS-1 specific antibody. Western blot signal 
intensities were quantified by densitometry and plotted as a function of the free Ca
2+
 
concentration present in the binding reaction. C) Recombinant CaM was incubated with 
GST-PQ, GST
IM→EE
 and GST-CBD in the presence or absence of 1M free Ca2+. Bound 
CaM was detected by Western blotting with a specific antibody. 
FIGURE 2 – Competitive interaction between NCS-1 and CaM for binding to GST-PQ. A) 
5M NCS-1 was incubated with 5 M GST-PQ in the presence of varying concentrations of 
CaM. Bound NCS-1 and CaM were visualised by Western blotting with specific antibodies. 
B) Data from (A) was quantified by densitometry and NCS-1/CaM bound to GST-PQ plotted 
as a function of the CaM concentration present in the binding assay. 
FIGURE 3 - Delineation of NCS-1 binding to PQ1909-2035. 
1
H-
15
N HSQC spectra of 
15
N-
labelled PQ1909-2035 in the presence (A) and absence of CaM (B) and of NCS-1 (C), 
showing the glycine amide resonance, and (D) tryptophan N

H resonances. (A) is the full 
15
N-
1
H spectrum; expanded regions show resonances from only glycine amide (B, C) and 
tryptophan indole (E) groups Amino acid sequence of PQ1909-2035 with glycine and 
tryptophan residues highlighted in bold blue. The likely CaM and NCS-1 binding region is 
indicated (15). 
FIGURE 4 - Binding of the PQIQ peptide to NCS-1 monitored using tryptophan fluorescence. 
Changes in tryptophan fluorescence following sequential additions of PQIQ peptide to the 
final concentrations indicated. Recombinant NCS-1 at a concentration of 1μM in a buffer 
(50mM Tris (pH 7.5), 50mM NaCl, 5mM CaCl2) was titrated with PQIQ at 50M—1mM in 
the same buffer conditions. The data were fitted using a logistic equation and non-linear 
curve fitting.  
FIGURE 5 - 
1
H TOCSY and HSQC spectra showing PQIQ-NCS-1 interactions (A) TOCSY 
spectrum of PQIQ peptide delineates NCS-1 binding region. Line-broadening was observed 
for selected resonances in the presence of a two-fold excess of NCS-1. Line-broadened 
resolved resonances from Y4, A7, A8, I11 and R16 are highlighted; aromatic resonances (left 
panel), aliphatic resonances (middle and right panels). (B) 
1
H-
15
N HSQC spectra of 
15
N NCS-
1 (0.8mM, black) in the presence of PQIQ (final concentration of 0.4mM, red) in 50mM Tris 
buffer (pH 6.5), 50mM NaCl, 5mM CaCl2, 300K. 
FIGURE 6 – Expression of NCS-1 and PQ in HeLa cells. A) HeLa cells were co-transfected 
with NCS-1-mCherry (red) and EYFP (green) or (green) and mCherry (red) or, B) NCS-1-
mCherry (red) and 
myr
PQ-YFP (green). Regions of co-localisation appear yellow in overlay 
images. Scale bars = 10m. C) Quantification of data from A & B. Cells were counted and 
scored for the presence of puncta (three independent experiments from each control condition 
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(NCS-1-mCh + EYFP and 
myr
PQ-YFP + mCherry, (A)) or four independent experiments 
from ((B) NCS-1-mCh + 
myr
PQ-YFP). The total number of cells counted for all experiments 
and for each condition is shown above the corresponding bar on the histogram. All data are 
plotted as mean ± SEM. 
 
Supplementary material 
Table 1 – Average densitometry data for 3 independent NCS-1/GST PQ binding assays 
described in Figure 1A. Maximal binding (NCS-1 bound to GST-PQ in the presence of 
calcium for all experiments) was set to 100% binding. Minimum binding for each assay 
(NCS-1 bound to either  GST-CBD or GST
IM→EE
 in the absence of calcium depending on the 
experiment) was set to 0% binding. All other data were normalised in this range.  
Condition Average NCS-1 bound (%) ± % (SEM, n=3) 
GST-PQ + Ca
2+
 100 - 
GST-PQ – Ca2+ 31.2 3.7 
GST-CBD + Ca
2+
 20.3 10.2 
GST-CBD – Ca2+ 4.9 4.9 
GST
IM→EE
 + Ca
2+
 10.3 3.9 
GST
IM→EE
 - Ca
2+
 2.8 2.0 
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